Provided by Tiger Trade Technology Pte. Ltd.

Eledon Pharmaceuticals, Inc.

3.03
+0.13184.54%
Volume:716.11K
Turnover:2.14M
Market Cap:227.49M
PE:-2.76
High:3.05
Open:3.01
Low:2.92
Close:2.90
52wk High:4.60
52wk Low:1.35
Shares:75.03M
Float Shares:74.99M
Volume Ratio:1.92
T/O Rate:0.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0976
EPS(LYR):-0.7454
ROE:-95.49%
ROA:-44.22%
PB:2.50
PE(LYR):-4.07

Loading ...

Top News Today: Stocks Mixed as AI Selloff Slows

Dow Jones
·
Nov 15, 2025

Eledon Pharmaceuticals Shares Sink After Pricing $50M Public Offering

Dow Jones
·
Nov 12, 2025

Eledon Pharmaceuticals Inc - Prices Public Offering of 15,152,485 Shares at $1.65 Each

THOMSON REUTERS
·
Nov 12, 2025

Eledon Pharmaceuticals Shares Fall 3.3% Premarket After Announcing Stock Offering

THOMSON REUTERS
·
Nov 12, 2025

BRIEF-Eledon Pharmaceuticals Announces Proposed Underwritten Public Offering Of Common Stock And Pre-Funded Warrants

Reuters
·
Nov 12, 2025

Eledon Pharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
Nov 12, 2025

Eledon Pharmaceuticals options imply 8.0% move in share price post-earnings

TIPRANKS
·
Nov 12, 2025

Noble Financial Keeps Their Buy Rating on Eledon Pharmaceuticals (ELDN)

TIPRANKS
·
Nov 10, 2025

Eledon Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $5 From $8

THOMSON REUTERS
·
Nov 10, 2025

Dow Dips Over 200 Points; Fluor Shares Slide After Q3 Results

Benzinga
·
Nov 08, 2025

Eledon Pharmaceuticals Inc expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
Nov 07, 2025

Eledon Pharmaceuticals Reports Positive Phase 2 Results for Tegoprubart in Kidney Transplant Rejection Prevention

Reuters
·
Nov 07, 2025

Eledon Presents Phase 2 Bestow Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology’s Kidney Week 2025 Annual Meeting

THOMSON REUTERS
·
Nov 07, 2025

Eledon Pharmaceuticals to Present Phase 2 BESTOW Trial Results of Tegoprubart for Kidney Transplant Rejection Prevention at ASN Kidney Week 2025

Reuters
·
Oct 17, 2025

Eledon Pharmaceuticals to Present on Anti-CD154 Pathway Blockade at International Xenotransplantation Association Congress

Reuters
·
Sep 25, 2025